Showing results (91-100 of 259) with videos related to
Sort By:
Pageof 26
Cancer Chemotherapy and Pharmacology|January 1, 1987
Metallothionein-mediated cisplatin resistance in human ovarian carcinoma cellsP A Andrews, M P Murphy, S B HowellThe Journal of Clinical Investigation|September 1, 1983
Regulation of de novo purine synthesis in human bone marrow mononuclear cells by hypoxanthineM E King, J M Honeysett, S B HowellGynecologic Oncology|March 1, 1990
A phase I clinical trial of intraperitoneal thiotepa for refractory ovarian cancerS Kirmani, L McVey, D Loo, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1984
Intraperitoneal cytosine arabinoside therapy in ovarian carcinomaM E King, C E Pfeifle, S B HowellCancer Communications|January 1, 1990
The effect of DNA polymerase inhibitors on the cytotoxicity of cisplatin in human ovarian carcinoma cellsE J Katz, P A Andrews, S B HowellEuropean Journal of Cancer & Clinical Oncology|April 1, 1989
Characterization of cisplatin-resistant COLO 316 human ovarian carcinoma cellsP A Andrews, M P Murphy, S B HowellMolecular Pharmacology|August 27, 1999
Molecular modeling of the intrastrand guanine-guanine DNA adducts produced by cisplatin and oxaliplatinE D Scheeff, J M Briggs, S B HowellMedical and Pediatric Oncology|January 1, 1982
Modulation of the cellular pharmacology and clinical toxicity of 1-beta-D-arabinofuranosylcytosineS B Howell, J A Streifel, C E PfeifleInternational Journal of Cancer|July 30, 1991
Modulation of cis-diamminedichloroplatinum(II) accumulation and sensitivity by forskolin and 3-isobutyl-1-methylxanthine in sensitive and resistant human ovarian carcinoma cellsS C Mann, P A Andrews, S B HowellCancer|July 1, 1986
Cisplatin administered by the intracavitary route as treatment for malignant mesotheliomaM Markman, S Cleary, C Pfeifle, et al.Pageof 26